WuXi PharmaTech Shareholders OK $3.3B Go-Private Deal
China-based research and development service provider WuXi PharmaTech on Wednesday said that its shareholders have approved a $3.3 billion deal with a consortium of private equity investors and the company's founders...To view the full article, register now.
Already a subscriber? Click here to view full article